– Strategic acquisition of UK genomics chief Congenica reinforces SeqOne market place and footprint – servicing over 160 labs in 30+ international locations – The acquisition creates the biggest international ‘software program pure participant’ within the scientific genomics house, which can keep UK presence on the famend Wellcome Sanger Institute SeqOne, a pioneer in AI-driven genomic evaluation,…
Collaboration Extends World Attain of Excessive-Efficiency Genomic Sequencing on the UG 100 Platform Ultima Genomics, Inc., developer of the UG 100 next-generation sequencing (NGS) platform, and Gene by Gene, a number one world supplier of superior genetic testing and genomic companies, at present introduced a partnership to broaden worldwide entry to high-quality, cost-effective DNA sequencing. By…
BeginNGS to display newborns for a couple of thousand treatable genetic issues Rady Kids’s Institute for Genomic Drugs (RCIGM®) at this time introduced an settlement with Sidra Drugs, a world-class specialty healthcare group for girls, youngsters and younger folks within the State of Qatar, to collaborate on implementing RCIGM’s genome-based new child screening program, BeginNGS (pronounced “beginnings”). Sidra…
Company reiterates its precision prevention commitment with latest expansion of its high-stakes cancer pledge—now targeting lung cancer, the world’s deadliest cancer. In a bold move to challenge one of the deadliest cancers worldwide , Human Longevity, Inc. (HLI) is expanding its high-profile $1 million pledge to include late-stage lung cancer—sending a clear signal that precision prevention is not just a promise, but a guarantee. Reflecting HLI’s…
LenioBio GmbH has been awarded EU4Health funding by the European Health and Digital Executive Agency (HaDEA), which implemented the corresponding call for proposals on behalf of the European Commission’s Health Emergency Preparedness and Response Authority (HERA). The project will focus on further development of the cell-free protein expression system, ALiCE®, as an innovative, rapid and on-demand…
Advanced NVIDIA GPU Integration Transforms Genome and Multiomics Alignment, Variant Calling and Reporting Capabilities Dante Omics AI, a pioneering force in computational genomics, today announced a groundbreaking upgrade to its proprietary genome and multiomics alignment, variant calling and reporting platform. The enhanced system leverages cutting-edge NVIDIA GPU technology to deliver unprecedented speed and accuracy in…
In a new article published in Value in Health, researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), collaborated with Novartis to examine how HEOR is transforming the evaluation and access pathways for cell and gene therapies (CGTs) for rare diseases. As CGTs move from experimental to increasingly approved treatments for rare…
Seamless analysis of high-dimensional multiomics and imaging data, alongside structured datasets, will drive the next wave of AI-driven scientific discovery. TileDB, the multimodal database pioneer, and Databricks, the Data and AI company, today announced a strategic partnership that eliminates data silos preventing healthcare and life sciences organizations from fully leveraging AI-driven drug discovery and clinical insights….
New collaboration between Aligning Science Across Parkinson’s and Allen Institute creates a common language for visualizing data from Parkinson’s and Alzheimer’s research Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson’s, Alzheimer’s, and other forms…
Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced successful mapping of the Respiratory Syncytial Virus (RSV) genome using its proprietary BioSeeker discovery engine to address one of global health’s most persistent and costly viral threats. By pinpointing highly conserved genomic targets, this mapping…